Scientists investigate whether a natural chemical drives osteoarthritis
NCT ID NCT05593640
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study explores whether a substance called thromboxane A2, which is involved in blood clotting and fat metabolism, also plays a role in osteoarthritis. Researchers will measure thromboxane levels in blood and joint fluid from 20 people with knee osteoarthritis and look for a link to disease severity. The goal is to better understand how this chemical affects cartilage cells, which could eventually lead to new treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If a link is found, this could point toward new treatments for osteoarthritis that target thromboxane.
What could go wrong
This is a small, early-stage study that only looks for correlations, not a treatment. It may not lead to any therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de NICE
RECRUITINGNice, 06003, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••